KBC Group NV Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

KBC Group NV raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 6,274 shares of the medical instruments supplier’s stock after purchasing an additional 1,040 shares during the period. KBC Group NV’s holdings in DENTSPLY SIRONA were worth $170,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. First Eagle Investment Management LLC boosted its stake in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the last quarter. Nuance Investments LLC grew its position in shares of DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after acquiring an additional 402,329 shares in the last quarter. Cooke & Bieler LP grew its position in shares of DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after acquiring an additional 1,046,105 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in DENTSPLY SIRONA by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after purchasing an additional 343,915 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $18.52 on Thursday. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $3.68 billion, a price-to-earnings ratio of -8.95, a P/E/G ratio of 1.81 and a beta of 1.02. The firm’s 50 day simple moving average is $23.54 and its 200 day simple moving average is $25.20.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% on a year-over-year basis. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Evercore ISI reduced their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research cut their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Needham & Company LLC dropped their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday. Seven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.